Shields AF - Search Results

1

Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study.

Munster P, Krop IE, LoRusso P, Ma C, Siegel BA, Shields AF, Molnár I, Wickham TJ, Reynolds J, Campbell K, Hendriks BS, Adiwijaya BS, Geretti E, Moyo V, Miller KD. Munster P, et al. Among authors: shields af. Br J Cancer. 2018 Oct;119(9):1086-1093. doi: 10.1038/s41416-018-0235-2. Epub 2018 Oct 26. Br J Cancer. 2018. PMID: 30361524 Free PMC article. Clinical Trial.

2

Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma.

Zalupski MM, Philip PA, LoRusso P, Shields AF. Zalupski MM, et al. Among authors: shields af. Cancer Chemother Pharmacol. 1997;40(3):225-7. doi: 10.1007/s002800050650. Cancer Chemother Pharmacol. 1997. PMID: 9219505 Clinical Trial.

3

A phase II study of carboplatin and paclitaxel in the treatment of patients with advanced esophageal and gastric cancer.

Philip PA, Zalupski MM, Gadgeel S, Hussain M, Shields A. Philip PA, et al. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-86-S19-88. Semin Oncol. 1997. PMID: 9427274 Clinical Trial.

4

Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.

Zalupski MM, Shields AF, Philip PA, Kraut M, LoRusso P, Heilbrun LK, Vaitkevicius V. Zalupski MM, et al. Among authors: shields af. Invest New Drugs. 1998;16(1):93-6. doi: 10.1023/a:1006087114621. Invest New Drugs. 1998. PMID: 9740550 Clinical Trial.

5

Phase II study of CI-958 in colorectal cancer.

Shields AF, Philip PA, LoRusso PM, Ferris AM, Zalupski MM. Shields AF, et al. Cancer Chemother Pharmacol. 1999;43(2):162-4. doi: 10.1007/s002800050878. Cancer Chemother Pharmacol. 1999. PMID: 9923823 Clinical Trial.

6

A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer.

Zonder JA, Shields AF, Zalupski M, Chaplen R, Heilbrun LK, Arlauskas P, Philip PA. Zonder JA, et al. Among authors: shields af. Clin Cancer Res. 2001 Jan;7(1):38-42. Clin Cancer Res. 2001. PMID: 11205915 Clinical Trial.

7

Phase II study of liposomal doxorubicin in patients with advanced colorectal cancer.

Shields AF, Lange LM, Zalupski MM. Shields AF, et al. Am J Clin Oncol. 2001 Feb;24(1):96-8. doi: 10.1097/00000421-200102000-00019. Am J Clin Oncol. 2001. PMID: 11232960 Clinical Trial.

8

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.

Philip PA, Zalupski MM, Vaitkevicius VK, Arlauskas P, Chaplen R, Heilbrun LK, Adsay V, Weaver D, Shields AF. Philip PA, et al. Among authors: shields af. Cancer. 2001 Aug 1;92(3):569-77. doi: 10.1002/1097-0142(20010801)92:3<569::aid-cncr1356>3.0.co;2-d. Cancer. 2001. PMID: 11505401 Clinical Trial.

9

Phase I clinical trial of 5-fluoro-pyrimidinone (5FP), an oral prodrug of 5-fluorouracil (5FU).

LoRusso PM, Prakash S, Wozniak A, Flaherty L, Zalupski M, Shields A, Sands H, Parchment R, Jasti B. LoRusso PM, et al. Invest New Drugs. 2002 Feb;20(1):63-71. doi: 10.1023/a:1014430216434. Invest New Drugs. 2002. PMID: 12003195 Free article. Clinical Trial.

10

Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancer.

Gadgeel SM, Shields AF, Heilbrun LK, Labadidi S, Zalupski M, Chaplen R, Philip PA. Gadgeel SM, et al. Among authors: shields af. Am J Clin Oncol. 2003 Feb;26(1):37-41. doi: 10.1097/00000421-200302000-00008. Am J Clin Oncol. 2003. PMID: 12576922 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

237 results

Search Page